Skip to main content
. 2020 Jun 27;12(7):597. doi: 10.3390/pharmaceutics12070597

Figure 10.

Figure 10

Modulation of Placebo-EMLs, SMV-raw, or optimized SMV-EMLs treatments on caspase-3 enzyme concentrations in MCF-7 cells. Values were normalized with respect to control untreated MCF-7 cells and are expressed as the percent variation of caspase 3. * Significantly different vs. Control (p < 0.05); # Significantly different vs. Placebo-EMLs (p < 0.05); $ Significantly different vs. SMV-raw (p < 0.05).